|Posted:||January 28, 2019 11:00 AM|
|From:||Representative Brian Sims|
|To:||All House members|
|Subject:||Insurance Coverage for Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) HIV Medication Package (Re-Introduction)|
|In 2017, there were over 960 new cases of HIV diagnosed in Pennsylvania and approximately 35,890 active cases across the Commonwealth. Although no cure or vaccine is currently available for HIV, certain antiretroviral medications can help to prevent the transmission of the disease. Unfortunately, these medications can often be far too expensive for the average citizen. As such, I invite you to join me in sponsoring a package of bills that would require insurance coverage of pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) HIV medications.
PrEP medications are available to HIV-negative individuals who are at high risk for contracting the disease. When taken daily and as prescribed, PrEP reduces the risk of acquiring HIV by more than 90% and can be even more effective when combined with other preventative measures. Unfortunately, a 30-day supply of PrEP can cost nearly $2,000, placing it out of reach for many Pennsylvanians. As such, we must work to ensure coverage for this groundbreaking and beneficial medication.
PEP medications are antiretroviral drugs that are designed to prevent people that have been potentially exposed to HIV from becoming infected. PEP is only available in emergency situations, typically 72 hours after potential exposure, and must be taken for a full 28 days in order to be effective. Without insurance, a full prescription for PEP can cost over $1,000, which can be prohibitive for many individuals. Much like PrEP, it is crucial that we increase access to this lifesaving medication.
Please join me in continuing the battle against HIV/AIDS and signing on as a co-sponsor. Thank you for your consideration.
Introduced as HB1294
|Description:||This bill would require insurance coverage for the expenses of any pre-exposure prophylaxis HIV medication.
Introduced as HB1295
|Description:||This bill would require insurance coverage for the expenses of any post-exposure prophylaxis HIV medication.